5-Amino-1MQ alternatives.

10 compounds compared to 5-Amino-1MQ, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

Start with a correction that reframes the whole search: 5-Amino-1MQ is not a peptide. It is a methylquinolinium salt, a substrate-site inhibitor of nicotinamide N-methyltransferase that came out of academic medicinal chemistry aimed at making membrane-permeable NNMT inhibitors, and it is only grouped with peptides by the research-chemical market. It is not approved by any major regulator, is not a recognized dietary supplement, and has no publicly documented IND or registered human clinical trials. It is not currently a WADA-listed prohibited substance by name, though its NAD+ and metabolic mechanism sits in an area anti-doping bodies watch. No NNMT inhibitor has human clinical data to move toward.

What you're comparing against
5-Amino-1MQ
F tier · 15/100Research / preclinical

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule, substrate-site inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT).

Ranked by evidence · strongest first
  1. 01
    AOD-9604
    D tierResearch / preclinical

    Acts through the adipose tissue and lipolysis signalling pathway, like 5-Amino-1MQ. Research / preclinical.

  2. 02
    HGH Fragment 176-191
    F tierResearch / preclinical
    hGH frag 176-191 · GH lipolytic fragment

    Acts through the adipose tissue and lipolysis signalling pathway, like 5-Amino-1MQ. Research / preclinical.

  3. 03
    Epitalon
    F tierResearch / preclinical

    Acts through the senescence and cellular ageing pathways pathway, like 5-Amino-1MQ. Research / preclinical.

  4. 04
    Adipotide
    F tierResearch / preclinical
    FTPP

    Acts through the adipose tissue and lipolysis signalling pathway, like 5-Amino-1MQ. Research / preclinical.

  5. 05
    FOXO4-DRI
    F tierResearch / preclinical

    Acts through the senescence and cellular ageing pathways pathway, like 5-Amino-1MQ. Research / preclinical.

  6. 06
    SS-31
    C tierIn human trials
    elamipretide

    Same category: longevity. In human trials.

  7. 07
    Glutathione
    D tierResearch / preclinical
    GSH · reduced glutathione

    Same category: longevity. Research / preclinical.

  8. 08
    MOTS-c
    F tierResearch / preclinical

    Same category: longevity. Research / preclinical.

  9. 09
    Humanin
    F tierResearch / preclinical

    Same category: longevity. Research / preclinical.

  10. 10
    Vilon
    F tierResearch / preclinical
    Lys-Glu dipeptide

    Same category: longevity. Research / preclinical.

How this list is built

An “alternative” here means a compound that shares 5-Amino-1MQ's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds